Medori R, Brooke M H, Waterston R H
Department of Neurology/Neurosurgery, Washington University Medical School, St. Louis, MO.
Neurology. 1989 Nov;39(11):1493-6. doi: 10.1212/wnl.39.11.1493.
Becker's muscular dystrophy is phenotypically heterogeneous, but the clinical expression is usually similar in patients within the same family. We report here 2 brothers affected with Becker's muscular dystrophy in whom the disease followed completely different courses. The disease started in both patients before their teens. However, the oldest sibling died at 37, following many years of severe disability, whereas the other sibling, now 26, has normal muscle strength. In addition, since the age of 13, the younger brother has had epilepsy and has been treated with phenytoin combined with other antiepileptic drugs. Analysis of the DNA from each of the 2 brothers revealed a similar deletion at the 5' end of the dystrophin gene. The different clinical courses despite the similar mutational event suggest that intrinsic muscle factors due to modified genes or environmental phenomena such as prolonged treatment with phenytoin or other antiepileptic agents may have influenced the clinical course.
贝克尔肌肉营养不良症在表型上具有异质性,但同一家族中的患者临床表现通常相似。我们在此报告2名患贝克尔肌肉营养不良症的兄弟,他们的病情发展过程截然不同。两名患者均在十几岁前发病。然而,年长的兄弟在经历多年严重残疾后,于37岁去世,而另一名兄弟现年26岁,肌肉力量正常。此外,自13岁起,弟弟患有癫痫,一直接受苯妥英钠联合其他抗癫痫药物治疗。对这2名兄弟的DNA分析显示,肌营养不良蛋白基因5'端存在相似的缺失。尽管突变事件相似,但临床病程不同,这表明修饰基因导致的内在肌肉因素或环境因素,如长期使用苯妥英钠或其他抗癫痫药物,可能影响了临床病程。